Alkaloid AD Skopje

Executive Summary

Alkaloid AD Skopje, founded in 1936, is a leading pharmaceutical company in North Macedonia with an integrated business model covering development, manufacturing, and marketing of generic prescription drugs, OTC products, and cosmetics. The company serves domestic and international markets across Southeast Europe, leveraging its long-standing reputation and diversified portfolio to maintain a stable revenue base. With a focus on generic drugs, Alkaloid benefits from rising demand for affordable medications in emerging markets and has recently expanded its production capacity to meet growing export needs. The company’s conservative financial management and lack of debt have enabled consistent profitability, though growth remains moderate due to limited R&D pipeline visibility and reliance on mature product lines. Alkaloid’s strategic initiatives include upgrading manufacturing facilities to EU-GMP standards and exploring partnerships for new product registrations in Western Europe and Asia.

Upcoming Catalysts (preview)

• Q3 2026Launch of new generic product line in Southeast European markets75% success
• TBDRegulatory approval for expanded manufacturing facility under EU-GMP standards85% success
• Q3 2026Strategic partnership or licensing deal for access to Western European markets50% success